The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients.
about
The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The efficacy and safety of end ...... static breast cancer patients.
@en
The efficacy and safety of end ...... static breast cancer patients.
@nl
type
label
The efficacy and safety of end ...... static breast cancer patients.
@en
The efficacy and safety of end ...... static breast cancer patients.
@nl
prefLabel
The efficacy and safety of end ...... static breast cancer patients.
@en
The efficacy and safety of end ...... static breast cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
The efficacy and safety of end ...... static breast cancer patients.
@en
P2093
Cheng Huang
Hongyu Zhen
Weiwei Huang
P2860
P304
31501-31507
P356
10.18632/ONCOTARGET.8967
P407
P577
2016-04-25T00:00:00Z